{
    "2021-01-11": [
        [
            {
                "time": "",
                "original_text": "医药行业周报：从历史复盘看“高景气度龙头”抱团趋势",
                "features": {
                    "keywords": [
                        "医药",
                        "行业周报",
                        "高景气度",
                        "龙头",
                        "抱团趋势"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "凯莱英参股子公司增资扩股构成关联交易 2250万引入产业资本",
                "features": {
                    "keywords": [
                        "凯莱英",
                        "参股子公司",
                        "增资扩股",
                        "关联交易",
                        "产业资本"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "2020年高瓴资本“生物医药”布局有何变化 投资逻辑究竟是啥？",
                "features": {
                    "keywords": [
                        "高瓴资本",
                        "生物医药",
                        "投资逻辑",
                        "布局变化"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "高瓴资本概念股普遍活跃，甘李药业、海正药业、凯莱英、良品铺子、金域医学大涨",
                "features": {
                    "keywords": [
                        "高瓴资本",
                        "概念股",
                        "甘李药业",
                        "海正药业",
                        "凯莱英",
                        "良品铺子",
                        "金域医学",
                        "大涨"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "消费品"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "拟20亿元投建绿色关键技术开发及产业化等项目 凯莱英持续加码新药研发服务市场",
                "features": {
                    "keywords": [
                        "凯莱英",
                        "20亿元",
                        "绿色关键技术",
                        "产业化",
                        "新药研发服务"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医疗健康行业：期待国产龙头打开内需和国际的双循环",
                "features": {
                    "keywords": [
                        "医疗健康",
                        "国产龙头",
                        "内需",
                        "国际",
                        "双循环"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物/行业周报：关注业绩超预期的机会",
                "features": {
                    "keywords": [
                        "医药生物",
                        "行业周报",
                        "业绩超预期",
                        "机会"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}